Nervonik: $52.5 Million Series B Raised To Advance Peripheral Nerve Stimulation Therapy
By Amit Chowdhry ● Yesterday at 11:16 AM
Nervonik, a clinical-stage medical device company focused on next-generation peripheral nerve stimulation, announced it has secured $52.5 million in an oversubscribed Series B financing round. The round was led by Amzak Health, with participation from Elevage Medical Technologies, U.S. Venture Partners, Lumira Ventures, Foothill Ventures, and Shangbay Capital.